Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Leukemia|January 26, 2024
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trialHjalmar Flygt, Stina Söderlund, Johan Richter, et al.
Oncotarget|February 11, 2017
Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitorsPaavo O Pietarinen, Christopher A Eide, Pilar Ayuda-Durán, et al.
Annals of Hematology|April 29, 2023
Switching from imatinib to nilotinib plus pegylated interferon-α2b in chronic phase CML failing to achieve deep molecular response: clinical and immunological effectsInge G P Geelen, Stein-Erik Gullaksen, Mette M Ilander, et al.
Leukemia|June 19, 2019
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemiaSusan Branford, Dennis Dong Hwan Kim, Jane F Apperley, et al.
Frontiers in Immunology|December 17, 2020
Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Blood|April 19, 2013
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemiaHanna L M Rajala, Samuli Eldfors, Heikki Kuusanmäki, et al.
Frontiers in Immunology|June 17, 2021
Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte SignatureTiina Kelkka, Paula Savola, Dipabarna Bhattacharya, et al.
Leukemia|September 16, 2025
Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CMLMikko Purhonen, Mikael Tatun, Katariina Luukkainen, et al.
Nature Medicine|May 16, 2017
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemiaAlice Giustacchini, Supat Thongjuea, Nikolaos Barkas, et al.
Blood|November 8, 2021
The similarity of class II HLA genotypes defines patterns of autoreactivity in idiopathic bone marrow failure disordersSimona Pagliuca, Carmelo Gurnari, Hassan Awada, et al.
Pageof 18